Alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cell

The goal of this dissertation is to investigate the interaction between cimetidine and dietary flavonoids using the Caco-2 cell transport model. It has been shown that flavonoids can change the bioavailability of pharmaceuticals, either by inhibiting metabolizing enzymes or inhibiting the drug efflu...

Full description

Bibliographic Details
Main Author: Taur, Jan-Shiang
Other Authors: Rodriguez, Rosita J.
Language:en_US
Published: 2012
Subjects:
Online Access:http://hdl.handle.net/1957/29868
id ndltd-ORGSU-oai-ir.library.oregonstate.edu-1957-29868
record_format oai_dc
spelling ndltd-ORGSU-oai-ir.library.oregonstate.edu-1957-298682012-07-03T14:37:28ZAlterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cellTaur, Jan-ShiangCimetidineFlavonoids -- Physiological effectDrug-nutrient interactionsThe goal of this dissertation is to investigate the interaction between cimetidine and dietary flavonoids using the Caco-2 cell transport model. It has been shown that flavonoids can change the bioavailability of pharmaceuticals, either by inhibiting metabolizing enzymes or inhibiting the drug efflux transporters. However, the effect of dietary flavonoids in the absorption of cimetidine has not been investigated. Therefore, the hypothesis of this study is that the absorption of cimetidine is mediated by a drug efflux pump, P-glycoprotein, of which dietary flavonoids can enhance the permeability of cimetidine by reducing P-glycoprotein function. The increase in permeability of cimetidine can increase the bioavailability of cimetidine. To test the hypothesis, three objectives were proposed. The first objective was to validate the Caco-2 transport model in our laboratory. The validation was performed by measuring the electrical resistance ofthe monolayer and determining the transport of paracellular marker. Also P-glycoprotein function was determined using rhodamine 123. The second objective was to describe the transport characteristics of cimetidine in the Caco-2 cell monolayers. The permeability of cimetidine was determined at different pH environments. When the permeability of cimetidine from apical to basolateral and basolateral to apical was compared, there appeared to be an effiux mechanism involved transport of cimetidine. The permeability of cimetidine in the presence of verapamil, a P-glycoprotein competitive inhibitor, suggested that P-glycoprotein was involved in the effiux. The third objective was to study the effect of dietary flavonoids on the permeability of cimetidine in the Caco-2 cell model. In the present study, four different flavonoids, quercetin, genistein, naringenin, and xanthohumol were selected. When co-treated with flavonoid aglycones, the permeability ofcimetidine was significantly reduced in the basolateral to apical direction. However, only genistin, a glycoside of genistein, significantly reduced the efflux of cimetidine. The present studies demonstrate that some dietary flavonoids, especially aglycones, can significantly reduce the effiux of cimetidine in the Caco-2 cell monolayers. Therefore, the fiavonoids consumed in a normal diet have the potential to enhance the bioavailability of cimetidine and possibly other P-glycoprotein substrates by altering their permeability.Graduation date: 2004Rodriguez, Rosita J.2012-06-14T19:28:05Z2012-06-14T19:28:05Z2003-07-232003-07-23Thesis/Dissertationhttp://hdl.handle.net/1957/29868en_US
collection NDLTD
language en_US
sources NDLTD
topic Cimetidine
Flavonoids -- Physiological effect
Drug-nutrient interactions
spellingShingle Cimetidine
Flavonoids -- Physiological effect
Drug-nutrient interactions
Taur, Jan-Shiang
Alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cell
description The goal of this dissertation is to investigate the interaction between cimetidine and dietary flavonoids using the Caco-2 cell transport model. It has been shown that flavonoids can change the bioavailability of pharmaceuticals, either by inhibiting metabolizing enzymes or inhibiting the drug efflux transporters. However, the effect of dietary flavonoids in the absorption of cimetidine has not been investigated. Therefore, the hypothesis of this study is that the absorption of cimetidine is mediated by a drug efflux pump, P-glycoprotein, of which dietary flavonoids can enhance the permeability of cimetidine by reducing P-glycoprotein function. The increase in permeability of cimetidine can increase the bioavailability of cimetidine. To test the hypothesis, three objectives were proposed. The first objective was to validate the Caco-2 transport model in our laboratory. The validation was performed by measuring the electrical resistance ofthe monolayer and determining the transport of paracellular marker. Also P-glycoprotein function was determined using rhodamine 123. The second objective was to describe the transport characteristics of cimetidine in the Caco-2 cell monolayers. The permeability of cimetidine was determined at different pH environments. When the permeability of cimetidine from apical to basolateral and basolateral to apical was compared, there appeared to be an effiux mechanism involved transport of cimetidine. The permeability of cimetidine in the presence of verapamil, a P-glycoprotein competitive inhibitor, suggested that P-glycoprotein was involved in the effiux. The third objective was to study the effect of dietary flavonoids on the permeability of cimetidine in the Caco-2 cell model. In the present study, four different flavonoids, quercetin, genistein, naringenin, and xanthohumol were selected. When co-treated with flavonoid aglycones, the permeability ofcimetidine was significantly reduced in the basolateral to apical direction. However, only genistin, a glycoside of genistein, significantly reduced the efflux of cimetidine. The present studies demonstrate that some dietary flavonoids, especially aglycones, can significantly reduce the effiux of cimetidine in the Caco-2 cell monolayers. Therefore, the fiavonoids consumed in a normal diet have the potential to enhance the bioavailability of cimetidine and possibly other P-glycoprotein substrates by altering their permeability. === Graduation date: 2004
author2 Rodriguez, Rosita J.
author_facet Rodriguez, Rosita J.
Taur, Jan-Shiang
author Taur, Jan-Shiang
author_sort Taur, Jan-Shiang
title Alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cell
title_short Alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cell
title_full Alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cell
title_fullStr Alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cell
title_full_unstemmed Alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, Caco-2 cell
title_sort alterations in the permeability of cimetidine by dietary flavonoids using an in vitro transport model, caco-2 cell
publishDate 2012
url http://hdl.handle.net/1957/29868
work_keys_str_mv AT taurjanshiang alterationsinthepermeabilityofcimetidinebydietaryflavonoidsusinganinvitrotransportmodelcaco2cell
_version_ 1716392455555776512